Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 4Phase 3 3Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Sarcoma 1

Conditions

Ewing's Sarcoma Family of Tumors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 242Carboplatin 137Nivolumab 132Gemcitabine 127Paclitaxel 116Cisplatin 105Cyclophosphamide 97Bevacizumab 93Dexamethasone 78Injections 75Pemetrexed 71Docetaxel 71Fluorouracil 68Capecitabine 65Rituximab 61Cetuximab 61atezolizumab 59130-nm albumin-bound paclitaxel 59Oxaliplatin 58Leucovorin 57Ipilimumab 54fludarabine 50Lenalidomide 47Azacitidine 40Irinotecan 39venetoclax 38Fulvestrant 38Albumin-Bound Paclitaxel 36Prednisone 35Trastuzumab 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × INDUSTRY × figitumumab × Clear all
NCT00560235 2015-10-28

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Pfizer

Phase 1/2 Completed
138 enrolled 15 charts
Sarcoma

Ewing's Sarcoma Family of Tumors

NCT00147537 2013-10-30

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

Pfizer

Phase 1/2 Completed
282 enrolled 25 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡